183 related articles for article (PubMed ID: 30321196)
1. Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening.
Chen Y; Yuan X; Xiao Z; Jin H; Zhang L; Liu Z
PLoS One; 2018; 13(10):e0205175. PubMed ID: 30321196
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
Cheung L; Flemming CL; Watt F; Masada N; Yu DM; Huynh T; Conseil G; Tivnan A; Polinsky A; Gudkov AV; Munoz MA; Vishvanath A; Cooper DM; Henderson MJ; Cole SP; Fletcher JI; Haber M; Norris MD
Biochem Pharmacol; 2014 Sep; 91(1):97-108. PubMed ID: 24973542
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy.
Döring H; Kreutzer D; Ritter C; Hilgeroth A
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375210
[TBL] [Abstract][Full Text] [Related]
4. Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991.
Becerra E; Berumen L; Soto-Ontiveros V; García-Alcocer G
Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743958
[No Abstract] [Full Text] [Related]
5. Topotecan is a substrate for multidrug resistance associated protein 4.
Tian Q; Zhang J; Chan SY; Tan TM; Duan W; Huang M; Zhu YZ; Chan E; Yu Q; Nie YQ; Ho PC; Li Q; Ng KY; Yang HY; Wei H; Bian JS; Zhou SF
Curr Drug Metab; 2006 Jan; 7(1):105-18. PubMed ID: 16454695
[TBL] [Abstract][Full Text] [Related]
6. Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen.
Cheung L; Yu DM; Neiron Z; Failes TW; Arndt GM; Fletcher JI
Biochem Pharmacol; 2015 Feb; 93(3):380-8. PubMed ID: 25462817
[TBL] [Abstract][Full Text] [Related]
7. Novel Symmetrical Cage Compounds as Inhibitors of the Symmetrical MRP4-Efflux Pump for Anticancer Therapy.
Kreutzer D; Döring H; Werner P; Ritter CA; Hilgeroth A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065900
[TBL] [Abstract][Full Text] [Related]
8. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
Peterson BG; Tan KW; Osa-Andrews B; Iram SH
Pharmacol Res; 2017 May; 119():313-326. PubMed ID: 28258008
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity.
Fukuda Y; Takenaka K; Sparreboom A; Cheepala SB; Wu CP; Ekins S; Ambudkar SV; Schuetz JD
Mol Pharmacol; 2013 Sep; 84(3):361-71. PubMed ID: 23775562
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine.
Peng XX; Shi Z; Damaraju VL; Huang XC; Kruh GD; Wu HC; Zhou Y; Tiwari A; Fu L; Cass CE; Chen ZS
Leuk Res; 2008 May; 32(5):799-809. PubMed ID: 17996297
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance-associated protein 4 is a determinant of arsenite resistance.
Yuan B; Yoshino Y; Fukushima H; Markova S; Takagi N; Toyoda H; Kroetz DL
Oncol Rep; 2016 Jan; 35(1):147-54. PubMed ID: 26497925
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
13. 6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4.
Janke D; Mehralivand S; Strand D; Gödtel-Armbrust U; Habermeier A; Gradhand U; Fischer C; Toliat MR; Fritz P; Zanger UM; Schwab M; Fromm MF; Nürnberg P; Wojnowski L; Closs EI; Lang T
Hum Mutat; 2008 May; 29(5):659-69. PubMed ID: 18300232
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells.
Wielinga PR; Reid G; Challa EE; van der Heijden I; van Deemter L; de Haas M; Mol C; Kuil AJ; Groeneveld E; Schuetz JD; Brouwer C; De Abreu RA; Wijnholds J; Beijnen JH; Borst P
Mol Pharmacol; 2002 Dec; 62(6):1321-31. PubMed ID: 12435799
[TBL] [Abstract][Full Text] [Related]
15. Structural and mechanistic basis of substrate transport by the multidrug transporter MRP4.
Bloch M; Raj I; Pape T; Taylor NMI
Structure; 2023 Nov; 31(11):1407-1418.e6. PubMed ID: 37683641
[TBL] [Abstract][Full Text] [Related]
16. CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.
Huynh T; Murray J; Flemming CL; Kamili A; Hofmann U; Cheung L; Roundhill EA; Yu DMT; Webber HT; Schwab M; Henderson MJ; Haber M; Norris MD; Fletcher JI
Biochem Pharmacol; 2020 Feb; 172():113770. PubMed ID: 31862449
[TBL] [Abstract][Full Text] [Related]
17. Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4.
Hardy D; Bill RM; Jawhari A; Rothnie AJ
SLAS Discov; 2019 Dec; 24(10):1000-1008. PubMed ID: 31381460
[TBL] [Abstract][Full Text] [Related]
18. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP).
Dankers AC; Mutsaers HA; Dijkman HB; van den Heuvel LP; Hoenderop JG; Sweep FC; Russel FG; Masereeuw R
Biochim Biophys Acta; 2013 Oct; 1832(10):1715-22. PubMed ID: 23665398
[TBL] [Abstract][Full Text] [Related]
20. Multidrug Resistance Protein 4 (MRP4/ABCC4) Protects Cells from the Toxic Effects of Halobenzoquinones.
Li J; Bauer M; Moe B; Leslie EM; Li XF
Chem Res Toxicol; 2017 Oct; 30(10):1815-1822. PubMed ID: 28885828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
